Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a new citation by Bocobo A. et al. to Publications for a 2026 Clin Colorectal Cancer article (Phase II study of pembrolizumab plus capecitabine and bevacizumab). Removed the previous Online ahead of print citation (Clin Colorectal Cancer, 2026 Feb 18:S1533-0028(26)00010-1).
    Difference
    0.0%
    Check dated 2026-07-11T00:28:01.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.6.2 to v3.6.3, signaling a new patch or update to the page. The visible content remains unchanged.
    Difference
    0.0%
    Check dated 2026-07-03T23:44:35.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.6.2 has been added, replacing Revision: v3.6.0. This reflects a page version update rather than any changes to the study details or eligibility information.
    Difference
    0.0%
    Check dated 2026-06-26T23:53:27.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The study page now indicates that recruitment has ended, clarifying participant eligibility. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, with a site revision tag updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T13:42:17.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page displays a new revision tag, changing from v3.5.4 to v3.5.5, indicating a minor CMS/template update. The change does not alter any study details, eligibility criteria, results, or navigational content.
    Difference
    0.0%
    Check dated 2026-06-05T09:18:47.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added, replacing the previous v3.5.3. This indicates a small update to the page metadata rather than a change to its substantive content.
    Difference
    0.0%
    Check dated 2026-05-15T05:15:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.